作者: Louiza Kalokairinou , Heidi C Howard , Pascal Borry
DOI: 10.1002/9780470015902.A0025181
关键词:
摘要: Currently, a wide variety of genetic tests are offered direct-to-consumer (DTC), often without involving healthcare professional. The potential benefits and harms such have caused controversy; proponents stress the right to information consumer empowerment, while concerns include questionable scientific quality utility harmful health decisions taken in absence medical supervision counselling. Studies indicate that despite relatively low public awareness regarding services, consumers value their motivation for buying ranges from acquiring health-related satisfying curiosity. Furthermore, professionals seem be sceptical this provision model some tests. ongoing revision European legislation regarding, among others, testing, recent regulatory action against testing company US DTC landscape may change significantly future. Key Concepts: Over last decade, commercial companies been offering non-health-related involvement providers. Various aspects numerous professionals, policy makers consumers, however, has also gained supporters. Consumers’ motivations using services vary widely. Healthcare providers seem, degree, testing. The Food Drug Administration recently adopted stricter position regulation by requiring 23andMe provide evidence safety efficacy its personal genome service. The EU Directive on vitro diagnostic devices is expected have, an important impact landscape. Keywords: direct-to-consumer; genetic testing; medical supervision; genetic counselling; regulation; consumers' awareness; healthcare professionals' attitudes